These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3101105)

  • 1. Effects of vasopressin, des-glycinamide vasopressin and amphetamine on a combined passive and active avoidance task.
    Sahgal A
    Psychopharmacology (Berl); 1986; 90(4):494-8. PubMed ID: 3101105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug effects on memory: assessment of a combined active and passive avoidance task.
    Sahgal A; Mason J
    Behav Brain Res; 1985 Oct; 17(3):251-5. PubMed ID: 4084395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position task in rats.
    Sahgal A
    Psychopharmacology (Berl); 1987; 93(2):243-9. PubMed ID: 3122257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive avoidance behavior, vasopressin and the immune system. A link between avoidance latency and immune response.
    Croiset G; Heijnen CJ; de Wied D
    Neuroendocrinology; 1990 Feb; 51(2):156-61. PubMed ID: 2106096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and amphetamine, but not desglycinamide vasopressin, impair positively reinforced visual attention performance in rats.
    Sahgal A
    Behav Brain Res; 1988 Jul; 29(1-2):35-42. PubMed ID: 3401320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of vasopressin to enhance memory in a passive avoidance task in rats.
    Sahgal A; Keith AB; Wright C; Edwardson JA
    Neurosci Lett; 1982 Jan; 28(1):87-92. PubMed ID: 7063145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS
    Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
    Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertonic saline mimics the effects of vasopressin on inhibitory avoidance in the rat.
    Lebrun C; Le Moal M; Dantzer R; Bloom FE; Koob GF
    Behav Neural Biol; 1987 Mar; 47(2):130-7. PubMed ID: 3579833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of vasopressin and oxytocin with amphetamine and chlordiazepoxide on passive avoidance behaviour in rats.
    Sahgal A; Wright C
    Psychopharmacology (Berl); 1983; 80(1):88-92. PubMed ID: 6408678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of DGAVP on acquisition and extinction of active avoidance behavior.
    Skopkova J; Croiset G; De Wied D
    Peptides; 1991; 12(3):471-5. PubMed ID: 1923926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of arginine-vasopressin in cerebrospinal fluid during passive avoidance behavior in rats.
    Laczi F; Gaffori O; Fekete M; de Kloet ER; de Wied D
    Life Sci; 1984 Jun; 34(24):2385-91. PubMed ID: 6727572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.
    Koob GF; Le Moal M; Gaffori O; Manning M; Sawyer WH; Rivier J; Bloom FE
    Regul Pept; 1981 Jun; 2(3):153-63. PubMed ID: 7255768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats.
    Packard MG; Ettenberg A
    Regul Pept; 1985 May; 11(1):51-63. PubMed ID: 4011956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin analogs: sedative properties and passive avoidance behavior in rats.
    Krejcí I; Kupková B; Metys J; Barth T; Jost K
    Eur J Pharmacol; 1979 Jul; 56(4):347-53. PubMed ID: 477729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septal vasopressin modulates motility and passive avoidance in pinealectomized rats.
    Appenrodt E; Schwarzberg H
    Physiol Behav; 1999 Jul; 66(5):757-61. PubMed ID: 10405103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.